^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Mantle Cell Lymphoma
    Drug:Ayvakit (avapritinib) (PDGFR antagonist, mutant c-KIT inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    Source:
    FDA
    Published date:
    06/16/2021
    Excerpt:
    YVAKIT is a kinase inhibitor indicated for… the treatment of adult patients…and mast cell leukemia (MCL).